FDA: Purveyors of phony botox targeting U.S. practices
(HealthDay)—Medical practices that purchase Botox may unwittingly be purchasing a fraudulent product not approved by the U.S. Food and Drug Administration for sale in the United States, according to an April 26 drug safety ...
Apr 29, 2013
0
0